Activist Saba Capital Reduces Stake in BlackRock ESG Capital Allocation Term Trust
ECAT is trading near its 52-week low of $13.35 (8.8% above the low).
Summary
Activist investor Saba Capital Management has sold approximately $15.68 million in shares of BlackRock ESG Capital Allocation Term Trust, reducing its stake from 23.69% to 22.72%.
Key Events · Ownership and Investor Activity · ECAT
-
Activist Reduces Stake
Saba Capital Management, an activist investor, decreased its beneficial ownership from approximately 23.69% to 22.72% of outstanding shares.
-
Significant Share Sales
The firm sold 970,031 common shares between February 26, 2026, and March 11, 2026, for a total value of approximately $15.68 million.
-
Follows Prior Activism
This filing updates the previous Schedule 13D/A from February 27, 2026, which detailed board nominations, indicating ongoing activist engagement.
Analysis · ECAT · Unknown
Saba Capital Management, a prominent activist investor, has reduced its beneficial ownership in BlackRock ESG Capital Allocation Term Trust by selling approximately $15.68 million worth of shares since its last Schedule 13D/A filing on February 27, 2026. This reduction in stake, from approximately 23.69% to 22.72%, indicates a partial divestment by the activist investor. While Saba Capital remains a significant shareholder, this sale could signal a shift in their engagement strategy or a move to realize profits.
At the time of this filing, ECAT was trading at $14.53 on NYSE in the Unknown sector. The 52-week trading range was $13.35 to $17.14. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.